These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30684003)

  • 1. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates.
    Cassetta L; Baekkevold ES; Brandau S; Bujko A; Cassatella MA; Dorhoi A; Krieg C; Lin A; Loré K; Marini O; Pollard JW; Roussel M; Scapini P; Umansky V; Adema GJ
    Cancer Immunol Immunother; 2019 Apr; 68(4):687-697. PubMed ID: 30684003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.
    Cassetta L; Bruderek K; Skrzeczynska-Moncznik J; Osiecka O; Hu X; Rundgren IM; Lin A; Santegoets K; Horzum U; Godinho-Santos A; Zelinskyy G; Garcia-Tellez T; Bjelica S; Taciak B; Kittang AO; Höing B; Lang S; Dixon M; Müller V; Utikal JS; Karakoç D; Yilmaz KB; Górka E; Bodnar L; Anastasiou OE; Bourgeois C; Badura R; Kapinska-Mrowiecka M; Gotic M; Ter Laan M; Kers-Rebel E; Król M; Santibañez JF; Müller-Trutwin M; Dittmer U; de Sousa AE; Esendağlı G; Adema G; Loré K; Ersvær E; Umansky V; Pollard JW; Cichy J; Brandau S
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32907925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.
    Bruger AM; Dorhoi A; Esendagli G; Barczyk-Kahlert K; van der Bruggen P; Lipoldova M; Perecko T; Santibanez J; Saraiva M; Van Ginderachter JA; Brandau S
    Cancer Immunol Immunother; 2019 Apr; 68(4):631-644. PubMed ID: 29785656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.
    Bruderek K; Schirrmann R; Brandau S
    Methods Mol Biol; 2021; 2236():1-7. PubMed ID: 33237535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasticity of myeloid-derived suppressor cells in cancer.
    Tcyganov E; Mastio J; Chen E; Gabrilovich DI
    Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly.
    Betsch A; Rutgeerts O; Fevery S; Sprangers B; Verhoef G; Dierickx D; Beckers M
    Blood Rev; 2018 Nov; 32(6):490-498. PubMed ID: 29691090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).
    Alfaro C; Teijeira A; Oñate C; Pérez G; Sanmamed MF; Andueza MP; Alignani D; Labiano S; Azpilikueta A; Rodriguez-Paulete A; Garasa S; Fusco JP; Aznar A; Inogés S; De Pizzol M; Allegretti M; Medina-Echeverz J; Berraondo P; Perez-Gracia JL; Melero I
    Clin Cancer Res; 2016 Aug; 22(15):3924-36. PubMed ID: 26957562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α-Deficiency in Myeloid Cells Leads to a Disturbed Accumulation of Myeloid Derived Suppressor Cells (MDSC) During Pregnancy and to an Increased Abortion Rate in Mice.
    Köstlin-Gille N; Dietz S; Schwarz J; Spring B; Pauluschke-Fröhlich J; Poets CF; Gille C
    Front Immunol; 2019; 10():161. PubMed ID: 30804946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis.
    Müller I; Janson L; Sauter M; Pappritz K; Linthout SV; Tschöpe C; Klingel K
    Viruses; 2021 May; 13(5):. PubMed ID: 34065891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity.
    Tumino N; Besi F; Martini S; Di Pace AL; Munari E; Quatrini L; Pelosi A; Fiore PF; Fiscon G; Paci P; Scordamaglia F; Covesnon MG; Bogina G; Mingari MC; Moretta L; Vacca P
    Front Immunol; 2021; 12():803014. PubMed ID: 35116033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Phenotyping of Splenic Myeloid-Derived Suppressor Cells in Murine Cancer Models.
    Sanseviero E; Kim R; Gabrilovich DI
    Methods Mol Biol; 2021; 2236():19-28. PubMed ID: 33237537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.
    Köstlin N; Vogelmann M; Spring B; Schwarz J; Feucht J; Härtel C; Orlikowsky TW; Poets CF; Gille C
    Immunology; 2017 Sep; 152(1):89-101. PubMed ID: 28464218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
    Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
    Front Immunol; 2019; 10():1401. PubMed ID: 31275327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.
    Aarts CEM; Hiemstra IH; Béguin EP; Hoogendijk AJ; Bouchmal S; van Houdt M; Tool ATJ; Mul E; Jansen MH; Janssen H; van Alphen FPJ; de Boer JP; Zuur CL; Meijer AB; van den Berg TK; Kuijpers TW
    Blood Adv; 2019 Nov; 3(22):3562-3574. PubMed ID: 31738831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDSCs in infectious diseases: regulation, roles, and readjustment.
    Dorhoi A; Glaría E; Garcia-Tellez T; Nieuwenhuizen NE; Zelinskyy G; Favier B; Singh A; Ehrchen J; Gujer C; Münz C; Saraiva M; Sohrabi Y; Sousa AE; Delputte P; Müller-Trutwin M; Valledor AF
    Cancer Immunol Immunother; 2019 Apr; 68(4):673-685. PubMed ID: 30569204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata.
    Zöller M; Zhao K; Kutlu N; Bauer N; Provaznik J; Hackert T; Schnölzer M
    Front Immunol; 2018; 9():1279. PubMed ID: 29951053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
    Baert T; Vankerckhoven A; Riva M; Van Hoylandt A; Thirion G; Holger G; Mathivet T; Vergote I; Coosemans A
    Front Immunol; 2019; 10():1273. PubMed ID: 31214202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotyping of Myeloid-Derived Suppressor Cells in Nonhuman Primates.
    Lin A; Loré K
    Methods Mol Biol; 2021; 2236():9-17. PubMed ID: 33237536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.
    Grassi G; Vanini V; De Santis F; Romagnoli A; Aiello A; Casetti R; Cimini E; Bordoni V; Notari S; Cuzzi G; Mosti S; Gualano G; Palmieri F; Fraziano M; Goletti D; Agrati C; Sacchi A
    Front Immunol; 2021; 12():594376. PubMed ID: 33981297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.
    Sangaletti S; Talarico G; Chiodoni C; Cappetti B; Botti L; Portararo P; Gulino A; Consonni FM; Sica A; Randon G; Di Nicola M; Tripodo C; Colombo MP
    Front Immunol; 2019; 10():1369. PubMed ID: 31281314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.